as on
| Source : NSE
as on August 26, 2025 at 4:01 pm IST
Day's Low
Day's High
1.11%
Downside
1.86%
Upside
52 Week's Low
52 Week's High
36.44%
Downside
7.05%
Upside
Market Stats | |
Previous Close | ₹756.60 |
Open | ₹756.60 |
Volume | 3.71L |
Upper Circuit | ₹907.90 |
Lower Circuit | ₹605.30 |
Day's Low | ₹737.5 |
Day's High | ₹759.7 |
52 Week Low | ₹474.05 |
52 Week High | ₹798.4 |
Returns % | |
1 Month Return | -3.27 % |
3 Month Return | + 14 % |
1 Year Return | + 47.87 % |
3 Year Return | + 213.27 % |
5 Year Return | + 274.04 % |
Check Kims market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹29,842.36 Cr
Return on Equity (ROE)
15.02
PE Ratio (TTM)
79.34
Return on capital employed (ROCE)
16.75
Industry PE ratio
53.56
Beta (LTM)
0.8
P/B Ratio
11.8
Dividend Yield
0PEG Ratio
52.75
Quarterly Earnings Growth YOY
-10.71
EPS (TTM)
10.37
Sector
Healthcare
Book Value
53.45
Technical Analysis
Bullish
View Technical Analysis
Track how Kims P/E has moved over time to understand its valuation trends.
Kims in the last 5 years
Lowest (6.82x)
June 30, 2021
Industry (53.56x)
August 26, 2025
Today (79.34x)
August 26, 2025
Highest (83.97x)
July 24, 2025
Today’s Price to Earnings Ratio: 79.34x
Get updated buy, sell, and hold recommendations by analysts on Kims.
based on 13 analysts
76.92%
Buy
7.69%
Hold
15.38%
Sell
76.92% of analysts recommend a 'BUY' rating for Kims. Average target price of ₹773.62
Source: S&P Global Market Intelligence
Get share price movements and forecasts by analysts on Kims.
Kims price forecast by 13 analysts
Upside of3.73%
High
₹885
Target
₹773.62
Low
₹630
Kims target price ₹773.62, a slight upside of 3.73% compared to current price of ₹745.8. According to 13 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Kims revenue growth forecast
Expected growth rate Q1, FY2027:61.42%
Forecast
Actual
Including amortisation and stock based compensations
Kims EPS growth forecast
EPS estimate Q1, FY2027:59.52%
Forecast
Actual
Source: S&P Global Market Intelligence
Get the annual and quarterly financial summary of Krishna Institute of Medical Sciences Ltd, including revenue, profit, loss and more.
View detailed summary of the earnings and dividend history of Kims.
Krishna Institute of Medical Sciences Ltd’s net profit fell -9.24% since last year same period to ₹78.60Cr in the Q1 2025-2026. On a quarterly growth basis, Krishna Institute of Medical Sciences Ltd has generated -22.79% fall in its net profits since last 3-months.
Read More about Earnings ResultsCheck stock indices that include Kims.
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Kims.
Investors | Holdings % | Quarterly Trend | 3M change |
---|---|---|---|
Promoter Holdings | 34.11% | ||
Foreign Institutions | 15.54% | 0.61 | |
Mutual Funds | 25.25% | ||
Retail Investors | 18.69% | 35.67 | |
Others | 6.4% |
Compare market cap, revenue, PE, and other key metrics of Kims with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
BUY | 29,842.36 | 54.81% | 0.79 | 414 | 3,035 | |
HOLD | 36,319.00 | 87.82% | 0.71 | 790 | 5,482 | |
BUY | 1,15,053.32 | 180.92% | 0.64 | 1,075 | 7,028 | |
BUY | 69,154.17 | 115.1% | 0.62 | 809 | 8,110 | |
BUY | 1,12,058.57 | 74.47% | 0.68 | 1,505 | 21,794 |
Latest news and events in one place to help you make informed investing decisions in Kims.
KIMS Q1 Results Show Mixed Financial Performance - 06 Aug, 2025
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 7 quarters, 609.09 Cr → 878.7 Cr (in ₹), with an average increase of 5.9% per quarter
Price Rise
In the last 3 months, KIMS stock has moved up by 14.0%
Retail Holding Up
Retail Investor have increased holdings from 13.78% to 18.69% in Jun 2025 quarter
FII Holding Up
Foreign Institutions have increased holdings from 15.45% to 15.54% in Jun 2025 quarter
Profit Down
Netprofit is down for the last 2 quarters, 101.8 Cr → 78.6 Cr (in ₹), with an average decrease of 22.8% per quarter
MF Holding Down
Mutual Funds have decreased holdings from 25.35% to 25.25% in Jun 2025 quarter
Promoter Holding Down
Promoters have decreased holdings from 38.82% to 34.11% in Jun 2025 quarter
Organisation | Krishna Institute of Medical Sciences Ltd |
Headquarters | Secunderabad |
Industry | Healthcare |
CEO | Bhaskara Rao Bollineni |
E-voting on shares | Click here to vote |
Check out the Mutual Funds with significant holdings in Kims.
Funds | Holdings | Prev. 5M |
---|---|---|
SBI Small Cap Fund Direct Plan Growth | 2.6% | |
HDFC Small Cap Fund-Direct Growth Option | 2.3% | |
Axis Small Cap Fund Direct Growth | 3.09% | |
Kotak Small Cap Direct Growth | 3.55% | |
SBI Multicap Fund Direct Growth | 2.18% |
Kims share price today stands at ₹745.8, Open: ₹756.6, Previous Close: ₹756.6, High: ₹759.7, Low: ₹737.5, 52 Week High: ₹798.4, 52 Week Low: ₹474.05 as on .
To buy Kims shares, you need to follow these steps:
Today's traded volume of Kims is 3.71L. Which means that 3.71L shares of Kims were bought and sold on the stock market during today's trading session.
Today's market capitalisation of Kims is ₹29,842.36 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
Kims’s 52 week high is ₹798.4 and 52 week low is ₹474.05. The current share price of Kims is ₹745.8, which is -6.59% down from its 52 week high and 57.33% up from its 52 week low.